Our Platform Technology

The investigational Lumicell™ Direct Visualization System (DVS)* has the potential to guide the removal of residual cancer in real time, thereby identifying cancer during the initial surgery that may otherwise remain undetected and recur or require a second surgery to address.

 

The system is comprised of an optical imaging agent, handheld device and patient-calibrated tumor detection software that work in concert to find, view and guide the resection of residual cancer after the surgeon is believed to be done with the initial tumor removal.

 

 

 

Watch a Case Study

 

*CAUTION: LUMISIGHT and Lumicell Direct Visualization System (DVS) are investigational products that are limited by Federal (or United States) law to investigational use. LUMISIGHT and Lumicell DVS are not authorized for marketing for any indication in any jurisdiction.